GSK PLC Sponsored ADR (GSK)
(Real Time Quote from BATS)
$41.66 USD
+0.55 (1.34%)
Updated Apr 29, 2024 02:37 PM ET
3-Hold of 5 3
A Value C Growth D Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
GSK 41.66 +0.55(1.34%)
Will GSK be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for GSK based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for GSK
Here's How to Play Pfizer (PFE) Stock Ahead of Q1 Earnings
Why the Market Dipped But GSK (GSK) Gained Today
GSK: What are Zacks experts saying now?
Zacks Private Portfolio Services
Illumina (ILMN) Expected to Beat Earnings Estimates: Should You Buy?
Top Stock Reports for Danaher, Regeneron Pharmaceuticals & Palo Alto Networks
GSK (GSK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Other News for GSK
Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week
UK earnings, trading statements calendar - next 21 days
UK earnings, trading statements calendar - next 7 days
Global company events calendar
Immatics N.V.: An Intriguing Developmental Concern